Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway
about
Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Combination Treatment with Apr ...... rough a STAT1 Dominant Pathway
@ast
Combination Treatment with Apr ...... rough a STAT1 Dominant Pathway
@en
type
label
Combination Treatment with Apr ...... rough a STAT1 Dominant Pathway
@ast
Combination Treatment with Apr ...... rough a STAT1 Dominant Pathway
@en
prefLabel
Combination Treatment with Apr ...... rough a STAT1 Dominant Pathway
@ast
Combination Treatment with Apr ...... rough a STAT1 Dominant Pathway
@en
P2093
P2860
P1476
Combination Treatment with Apr ...... rough a STAT1 Dominant Pathway
@en
P2093
Gerald Wang
Jane Yanagawa
Kostyantyn Krysan
Maie St John
Mi-Heon Lee
Paul C Pagano
Puja Kachroo
Sherven Sharma
Steven M Dubinett
P2860
P304
P356
10.4172/1948-5956.1000310
P577
2014-11-15T00:00:00Z